Investor

OrbiMed Asia

Filed with the SEC to raise a fund in Oct 2026, closing $1,046M. Last cheque observed Mar 2019.

QuietNew fund $1.0B, Oct 2026Private equity

Series ASeries C

Cheques on record
0%of best year0cheques in 12 months, 3 on record
Since the last cheque2785days00hrs00min00sec
Median round$19MRounds led1 of 3Sole investor1 rounds
Pitch OrbiMed Asia

OrbiMed Asia highlights

  1. 01

    3 rounds on record

  2. 02

    Mostly Series A and Series C: 100% of its rounds

  3. 03

    Sole investor in 1 rounds, median $9.8M

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first3 appearances

  1. 2019

    1 round

  2. Mar
    InventisBioSeries C · CN · FinSMEs$70MWith 4 others
  3. 2018

    1 round

  4. Jun
    LaeknaSeries A · CN · Biocentury$19MLed
  5. 2016

    1 round

  6. Aug
    CBT PharmaceuticalsSeries A · US · FinSMEs$9.8MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration8 named

CLCarl L. GordonDirector of the GPLTDiFiling they signed
DGDavid G. WangDirector of the GPLTDiFiling they signed
JGJonathan G. WangDirector of the GPLTDiFiling they signed
JTJonathan T. SilversteinDirector of the GPLTDiFiling they signed
SDSamuel D. IsalyDirector of the GPLTDiFiling they signed
SCSunny Carter SharmaDirector of the GPLTDiFiling they signed
SHSven H. BorhoDirector of the GPLTDiFiling they signed
WCW. Carter NeildDirector of the GPLTDiFiling they signed

We also hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Recently backed

The latest companies OrbiMed Asia put money into.

InventisBio$70M · Mar 2019

Quick answers about OrbiMed Asia

What does OrbiMed Asia invest in?

OrbiMed Asia invests most often at Series A and Series C (100% of the rounds on record).

How active is OrbiMed Asia?

3 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Mar 2019.

What has OrbiMed Asia invested in recently?

Its most recent investments on record: InventisBio (Series C, Mar 2019), Laekna (Series A, Jun 2018) and CBT Pharmaceuticals (Series A, Aug 2016).

How big are OrbiMed Asia's cheques?

The median round it joins is $19M.

Is OrbiMed Asia investing now?

No investments in the last 12 months; the latest was in Mar 2019.

What kind of investor is OrbiMed Asia?

OrbiMed Asia is a private equity firm.

Has OrbiMed Asia raised a new fund?

Its latest fund filing with the SEC was in Oct 2026, reporting $1.0B raised.

Where does this information on OrbiMed Asia come from?

From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it